-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, China Resources Shuanghe's medium/long chain fat emulsion (C8-24) officially obtained the "Drug Registration Certificate" (certificate number: 2021S00036, 2021S00037), which will further enrich the company's product line, help to enhance the market competitiveness of the company's products.
the drug as an extraintestinal nutrition drug, energy supplement, used for gastrointestinal nutrition, to meet the requirements of energy and essential fatty acids.
was developed by the German company Belang and approved for listing in Europe in 1990 under the name "Lipofundina MCT/LCT", which was licensed for import and marketed in China in 2001 and has been listed and sold in dozens of countries around the world, including China, Europe, Russia, Saudi Arabia and Indonesia.
in China, 11 of the drug's approved companies have been listed.
2019, global sales of "Lipofundina MCT/LCT" were $25.202 million, according to PharMarket database.
according to Mienet data, in the first half of 2020 medium/long-chain fat emulsion (C8-24) and medium/long-chain fat emulsion (C8-24Ve) total domestic sales (end price) of 731 million yuan.
